Kinetic analysis. Experiments used to determine the kinetic parameters of FrbJ were carried out in triplicate. Each reaction mixture (100 µL final volume) contained 0.2 μM FrbJ, 200 μM Fe(II)SO 4 , 800 μM ascorbic acid in 50 mM HEPES-Na + buffer (pH 7.25). For the determination of substrate kinetic parameters, the αKG concentration was held constant at 10 mM while the specified substrate concentration ranged from 0-2.5 mM. For the determination of K M with αKG, the FR-900098 concentration was held constant at 1 mM while the final concentration of αKG ranged from 0-10 mM. All reactions were initiated by the addition of recombinant FrbJ and run at 25 °C. Aliquots were taken and quenched by the addition of 4% trifluoroacetic acid and were kept at 4 °C until analysis by HPLC. The kinetic parameters were obtained after analyzing the extracted ion chromatograms for product formation by LC-MS. Methods for liquid chromatography separation and mass spectroscopy were previously described 1 .
Antimalarial compound library creation. Overexpression strains for DhpI and Pfs contained His 6 -tags making them amenable to purification similar to FrbJ. Commercially available FR-900098 and fosmidomycin were the starting substrates for the antimalarial compound library. These two compounds (5 mM) were incubated with 25 μM purified His 6 -FrbJ, 10 mM αKG, 200 μM Fe(II)SO 4 , and 800 μM ascorbic acid. Reaction mixtures were kept at 25 °C for 24 h to ensure complete conversion to products.
Samples were then transferred into a Microcon ® centrifugal filter device (MWCO 10,000) (Millipore; Billerica, MA) and centrifuged for 10 minutes at maximum speed to remove enzyme, yielding solutions of FR-33289 and hydroxyfosmidomycin. These hydroxylated samples, FR-900098, and fosmidomycin were then used as substrates for the second in vitro reaction. These four compounds (5 mM) were incubated with 25 μM purified His 6 -DhpI, 25 μM purified His 6 -Pfs, and 10 mM SAM at 25 °C for 24 h. DhpI, like many other methyltransferases, undergoes product inhibition by the product Sadenosylhomocysteine (SAH) 2 . As a result, SAH nucleosidase, which catalyzes SAH hydrolysis to adenine and S-ribosylhomocysteine, was added to in vitro reaction mixtures to ensure complete conversion to the desired methylated phosphonate. Once again, samples were transferred into a Microcon® centrifugal filter device (MWCO 10,000) and centrifuged for 10 min at maximum speed to remove enzyme, yielding solutions of O-methylated phosphonates. The prospective antimalarial library was then purified by HPLC separation using a method identical to that in the kinetic analysis, as mentioned earlier 1 . Fractions were collected and then checked for purity before final lyophilization to dryness.
Bioauthentication by E. coli bioassay. The E. coli bioassay strain WM6242 contains three phosphonate uptake genes phnCDE, expression of which creates a hypersensitive E. coli strain to phosphonate antibiotics 3 . The FR-900098-sensitive E. coli strain used in these bioassays was strain WM6242 transformed with pETDuet, pRSFDuet, and pACYCDuet to ensure ampicillin, kanamycin, and chloramphenicol resistance, respectively. Although not required in the assays described here, inclusion of these plasmids protects against any background antimicrobial activity from antibiotics in the spent medium of E. coli FR-900098 production strains. FR-900098-resistant E. coli strains were created by transforming WM6242 with pMal-c2x-dxrB and pMal-c2x-ispC (cloned under P tac promoter without maltose binding protein fusion), respectively, in addition to pRSFDuet and pACYCDuet. Overnight cultures of the three strains were grown in LB media with the following antibiotic concentrations: ampicillin, 50 µg/mL; kanamycin, 25 µg/mL; and chloramphenicol, 12.5 µg/mL. Saturated overnight cultures were diluted 10-fold in LB media and 100 µL was mixed with 3 mL of 1.0% top agar. The mixture was spread on Antibiotic 2 media + 0.4 mM IPTG plates and allowed to solidify. Blank paper discs were impregnated with sample and incubated overnight at 37 °C, after which they were added to the agar plates and analyzed for zones of growth inhibition.
Bioauthentication by pfDxr inhibition. The full-length dxr gene from Plasmodium falciparum was codon-optimized for expression in E. coli by DNA 2.0 (Menlo Park, CA) and the sequence encoding the 72 amino acid long signal peptide was later removed to increase soluble expression [4] [5] . An N-His 6 -tag was introduced to the shortened protein making it amenable to purification similar to FrbJ. The inhibition of the enzymatic activity of pfDxr was determined in triplicate at 25 °C. Each reaction mixture (300 µL final volume) contained 50 nM pfDxr, 300 μM NADPH, 1 mM MnCl 2 in 50 mM HEPES-Na + buffer (pH 7.25). The reaction was monitored by NADPH oxidation at 340 nm. For the determination of IC 50 values, substrate concentration was held at 250 µM and inhibitor concentrations of 0-500 nM were used. For the determination of K I values, substrate concentration ranged from 0-250 µM and inhibitor concentrations of 0-100 nM were used. Figure 1 . Growth inhibition assays of (A) FR-900098-sensitive E. coli strain and (B) FR-900098-resistant E. coli strain. Discs labeled 1 were soaked with ddH 2 O; discs labeled 2 were soaked with FR-900098; discs labeled 3 were soaked with FR-33289; discs labeled 4 were soaked with fosmidomycin; and discs labeled 5 were soaked with hydroxyfosmidomycin. The FR-900098-sensitive strain produced inhibition zones for all the bioactive compounds, while the FR-900098-resistant strains (containing dxrB or ispC) did not produce inhibition zones for any of the phosphonates. 
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